Comparison · NCT01907269-d287b278
Video-based Intervention vs Usual Care: Number of Participants That Initiate an Osteoporosis Prescription Medication
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Video-based Intervention vs Usual Care: Number of Participants That Initiate an Osteoporosis Prescription Medication. Trial comparisons, record NCT01907269-d287b278. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01907269-d287b278
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.117 | 0.101 | 0.135 | wilson | |
| Risk in group 2 | 0.114 | 0.0981 | 0.132 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00298 | -0.0213 | 0.0272 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.03 | 0.832 | 1.27 | log | |
| Odds ratio, group 1 over group 2 | 1.03 | 0.813 | 1.3 | log | |
| Number needed to treat, for one more participant with the outcome on Video-based Intervention than on Usual Care | 336 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Video-based Intervention | Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use story-telling delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.~Video-based Intervention: Video clips delivered by DVD and Internet | 157 | 1,342 | OG000 |
| Group 2 | Usual Care | 153 | 1,342 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Number of Participants That Initiate an Osteoporosis Prescription Medication
- Description
We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.
- Time frame
- 6 months post-intervention
- Population
- For the Intent-to-Treat Analysis the data was imputed for non-responders.
Source ClinicalTrials.gov
Trial
- Title
- A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care
- NCT number
- NCT01907269
- Phases
- NA
- Conditions
- Osteoporosis
- Interventions
- Video-based Intervention
- Lead sponsor
- University of Alabama at Birmingham
- Results first posted
- 2018-06-26
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01907269?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01907269-d287b278